Treatment for Healthy 52-Year-Old Female with RSV
A healthy 52-year-old woman with RSV requires only supportive care—no antiviral therapy is indicated. 1, 2
Primary Management Approach
Supportive care is the cornerstone of treatment for immunocompetent adults with RSV infection. 1, 2 This includes:
- Adequate hydration and fluid intake assessment 3, 2
- Acetaminophen or ibuprofen for fever or pain management 3, 2
- Nasal saline irrigation for symptomatic relief of upper respiratory symptoms 3
- Supplemental oxygen only if oxygen saturation falls persistently below 90% 3, 2
What NOT to Use
Ribavirin should NOT be used in immunocompetent adults with RSV. The Infectious Diseases Society of America and American College of Physicians explicitly recommend against routine ribavirin use in healthy adults with RSV pneumonia (D-I recommendation). 1 Ribavirin is reserved exclusively for moderately to severely immunocompromised patients—specifically hematopoietic stem cell transplant recipients, solid organ transplant recipients, and those on active chemotherapy. 1
Palivizumab has no therapeutic benefit for treating established RSV infection and should never be used for treatment—it is only approved for prophylaxis in high-risk infants. 1, 3, 2
Corticosteroids should not be used routinely for RSV infection management. 3, 2
Antibiotics should only be used if specific indications of bacterial co-infection exist, not for RSV infection itself. 3, 2
Clinical Monitoring
For a healthy adult, monitor for signs of clinical deterioration that would warrant escalation of care:
- Persistent oxygen saturation <90% 3, 2
- Severe respiratory distress with rising PaCO2 (>6.5 kPa) 3
- Inability to maintain adequate oral intake 3
- Altered mental status or lethargy 3
Infection Control
Hand hygiene is the single most important measure to prevent RSV transmission to others. 3, 4 The patient should:
- Practice frequent hand washing or use alcohol-based hand sanitizers 3, 2
- Avoid close contact with high-risk individuals (infants, elderly, immunocompromised persons) during the acute illness 3
Common Pitfalls to Avoid
Do not prescribe ribavirin for previously healthy adults with RSV, as the evidence does not support benefit and exposes patients to unnecessary risks (hemolytic anemia, liver dysfunction, teratogenicity) and costs. 1
Do not order RSV testing in routine outpatient cases where management will be supportive regardless, as it does not change management in immunocompetent adults. 3
Avoid overuse of antibiotics without evidence of bacterial co-infection, which contributes to antimicrobial resistance. 2
Prevention for Future Seasons
RSV vaccination is now available and recommended for adults ≥60 years with risk factors and all adults ≥75 years. 3 While this patient at age 52 does not currently meet age-based criteria, she should be counseled about vaccination eligibility as she approaches 60, particularly if she develops cardiopulmonary disease or other risk factors. 3, 5, 6